Review
Early studies of etoposide phosphate, a water-soluble prodrug
Affiliations
- PMID: 8996570
Item in Clipboard
Review
Early studies of etoposide phosphate, a water-soluble prodrug
Semin Oncol.
1996 Dec.
Abstract
Etoposide phosphate (Etopophos; Bristol-Myers Squibb Company, Princeton, NJ) is a water-soluble prodrug of etoposide that is converted in vivo by endogenous phosphatases to the active drug etoposide. This conversion process is efficient and not saturable in humans at doses between 50 and 1,600 mg/m2. The resultant etoposide demonstrates classic pharmacokinetics, and the etoposide phosphates dose is linearly related to peak levels and the area under the concentration-time curve of etoposide. The absence of noxious solvents and the ability to administer the drug in small volumes over short periods make etoposide a phosphate attractive for conventional- and high-dose clinical programs.
Similar articles
-
Effects of gender, age, and race on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients.Semin Oncol. 1996 Dec;23(6 Suppl 13):23-9. Semin Oncol. 1996. PMID: 8996572
-
Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.Semin Oncol. 1996 Dec;23(6 Suppl 13):34-44. Semin Oncol. 1996. PMID: 8996574 Clinical Trial.
-
Etoposide phosphate: what, why, where, and how?Semin Oncol. 1996 Dec;23(6 Suppl 13):1-7. Semin Oncol. 1996. PMID: 8996569 Review.
-
A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patients.Semin Oncol. 1996 Dec;23(6 Suppl 13):15-22. Semin Oncol. 1996. PMID: 8996571 Clinical Trial.
-
Etoposide phosphate, the water soluble prodrug of etoposide.Pharm World Sci. 1996 Oct;18(5):163-70. doi: 10.1007/BF00820727. Pharm World Sci. 1996. PMID: 8933576 Review.
Cited by
-
Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives.Molecules. 2015 Feb 16;20(2):3255-80. doi: 10.3390/molecules20023255. Molecules. 2015. PMID: 25690288 Free PMC article.
-
Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.Med Res Rev. 2015 Jan;35(1):1-62. doi: 10.1002/med.21319. Epub 2014 May 14. Med Res Rev. 2015. PMID: 24827545 Free PMC article. Review.